Tao Synergies Inc (TAOX)

[Plummy Potter]

This make a lot of sense. In fact, the previous two PRs announced that the company had concluded "dosing and monitoring" (2017) and "data collection" (2019). They won't be able to make those claims in this case until the 42 week follow-up has been completed for all patients. Not sure when to expect that...

https://www.prnewswire.com/news-releases/neurotrope-bioscience-concludes-patient-dosing-and-monitoring-in-its-148-patient-phase-2-clinical-trial-of-moderate-to-severe-alzheimers-dementia-300414678.html

https://www.americanpharmaceuticalreview.com/1315-News/362700-Neurotrope-Concludes-Data-Collection-in-Alzheimer-s-Disease-Clinical-Trial/